Home Living + Wellness Promising Oklahoma-made cancer drug in clinical trials

Promising Oklahoma-made cancer drug in clinical trials

by The 100 Companies

University of Oklahoma College of Medicine Professor Doris Benbrook, Ph.D., has curated a new cancer drug, named OK-1 to treat and prevent ovarian, endometrial and cervical cancers.

After receiving FDA approval to be tested in a human phase I clinical trial, the drug showed little toxicity to patients while also shrinking tumors by attacking only unhealthy cells. This groundbreaking process leads to a less stressful and less painful treatment for most cases.

Upon further trials, the Oklahoma-made drug could be given to women with a genetic predisposition to cancer if OK-1 is shown to effectively prevent this disease.

Addie Maze, Jones PR

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

The Oklahoma 100